These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23354951)

  • 1. Alternative splicing of BRAF transcripts and characterization of C-terminally truncated B-Raf isoforms in colorectal cancer.
    Hirschi B; Kolligs FT
    Int J Cancer; 2013 Aug; 133(3):590-6. PubMed ID: 23354951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma.
    Baitei EY; Zou M; Al-Mohanna F; Collison K; Alzahrani AS; Farid NR; Meyer B; Shi Y
    J Pathol; 2009 Apr; 217(5):707-15. PubMed ID: 19156774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
    Matos P; Oliveira C; Velho S; Gonçalves V; da Costa LT; Moyer MP; Seruca R; Jordan P
    Gastroenterology; 2008 Sep; 135(3):899-906. PubMed ID: 18602919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The landscape of BRAF transcript and protein variants in human cancer.
    Marranci A; Jiang Z; Vitiello M; Guzzolino E; Comelli L; Sarti S; Lubrano S; Franchin C; Echevarría-Vargas I; Tuccoli A; Mercatanti A; Evangelista M; Sportoletti P; Cozza G; Luzi E; Capobianco E; Villanueva J; Arrigoni G; Signore G; Rocchiccioli S; Pitto L; Tsinoremas N; Poliseno L
    Mol Cancer; 2017 Apr; 16(1):85. PubMed ID: 28454577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity PCR method for detecting BRAF V600E mutations in metastatic colorectal cancer using LNA/DNA chimeras to block wild-type alleles.
    Chen D; Huang JF; Xia H; Duan GJ; Chuai ZR; Yang Z; Fu WL; Huang Q
    Anal Bioanal Chem; 2014 Apr; 406(9-10):2477-87. PubMed ID: 24500755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.
    Fransén K; Klintenäs M; Osterström A; Dimberg J; Monstein HJ; Söderkvist P
    Carcinogenesis; 2004 Apr; 25(4):527-33. PubMed ID: 14688025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.
    Kondo T; Nakazawa T; Murata S; Kurebayashi J; Ezzat S; Asa SL; Katoh R
    Hum Pathol; 2007 Dec; 38(12):1810-8. PubMed ID: 17714762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.
    Preto A; Figueiredo J; Velho S; Ribeiro AS; Soares P; Oliveira C; Seruca R
    J Pathol; 2008 Feb; 214(3):320-7. PubMed ID: 18098337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of spliced variants of the proto-oncogene HDM2 in colorectal cancer.
    Yu Z; Zhang B; Cui B; Wang Y; Han P; Wang X
    Cancer; 2012 Feb; 118(4):1110-8. PubMed ID: 21761395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic deletions explain the generation of alternative BRAF isoforms conferring resistance to MAPK inhibitors in melanoma.
    Aya F; Lanuza-Gracia P; González-Pérez A; Bonnal S; Mancini E; López-Bigas N; Arance A; Valcárcel J
    Cell Rep; 2024 Apr; 43(4):114048. PubMed ID: 38614086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of BRAF 3'UTR Isoforms in Melanoma.
    Marranci A; Tuccoli A; Vitiello M; Mercoledi E; Sarti S; Lubrano S; Evangelista M; Fogli A; Valdes C; Russo F; Monte MD; Caligo MA; Pellegrini M; Capobianco E; Tsinoremas N; Poliseno L
    J Invest Dermatol; 2015 Jun; 135(6):1694-1697. PubMed ID: 25685929
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
    Yao KS; Godwin AK; Johnson C; O'Dwyer PJ
    Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-Raf inhibitors induce epithelial differentiation in BRAF-mutant colorectal cancer cells.
    Herr R; Köhler M; Andrlová H; Weinberg F; Möller Y; Halbach S; Lutz L; Mastroianni J; Klose M; Bittermann N; Kowar S; Zeiser R; Olayioye MA; Lassmann S; Busch H; Boerries M; Brummer T
    Cancer Res; 2015 Jan; 75(1):216-29. PubMed ID: 25381152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF.
    Emuss V; Garnett M; Mason C; Marais R
    Cancer Res; 2005 Nov; 65(21):9719-26. PubMed ID: 16266992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology.
    Benlloch S; Payá A; Alenda C; Bessa X; Andreu M; Jover R; Castells A; Llor X; Aranda FI; Massutí B
    J Mol Diagn; 2006 Nov; 8(5):540-3. PubMed ID: 17065421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma.
    Eisenhardt AE; Olbrich H; Röring M; Janzarik W; Anh TN; Cin H; Remke M; Witt H; Korshunov A; Pfister SM; Omran H; Brummer T
    Int J Cancer; 2011 Nov; 129(9):2297-303. PubMed ID: 21190184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of B-raf isoforms by phosphorylation and autoinhibitory mechanisms.
    Hmitou I; Druillennec S; Valluet A; Peyssonnaux C; Eychène A
    Mol Cell Biol; 2007 Jan; 27(1):31-43. PubMed ID: 17074813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E.
    Lee MH; Lee SE; Kim DW; Ryu MJ; Kim SJ; Kim SJ; Kim YK; Park JH; Kweon GR; Kim JM; Lee JU; De Falco V; Jo YS; Shong M
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E19-30. PubMed ID: 20926530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.